Musser C J, Ahmann P A, Theye F W, Mundt P, Broste S K, Mueller-Rizner N
Department of Epidemiology and Biostatistics, Marshfield Medical Research and Education Foundation, USA.
J Dev Behav Pediatr. 1998 Jun;19(3):187-92. doi: 10.1097/00004703-199806000-00006.
The purpose of this study was to describe stimulant use and abuse as reported by school administrators and children diagnosed with attention deficit/hyperactivity disorder or attention deficit disorder inattentive. Five years after being identified as Ritalin responders, 161 children were surveyed regarding stimulant use and abuse. School principals in central Wisconsin were also surveyed regarding stimulant use and policies. No child believed stimulants as prescribed could lead to abuse. Sixteen percent of the children had been approached to sell, give, or trade their medication. During school hours, 44% of children and 37% of schools reported stimulants were stored unlocked. Not all schools had written policies regarding prescription drugs, and 10% permitted students to carry their own medication. Monitoring prescription usage, periodic reassessment of efficacy, and continuing education of family and teaching staff should be part of the multimodal treatment for this disorder. School policies should be developmentally sensitive.
本研究的目的是描述学校管理人员以及被诊断为注意力缺陷/多动障碍或注意力不集中型注意力缺陷障碍的儿童所报告的兴奋剂使用和滥用情况。在被确定为利他林反应者五年后，对161名儿童进行了关于兴奋剂使用和滥用情况的调查。还对威斯康星州中部的学校校长进行了关于兴奋剂使用和政策的调查。没有儿童认为按处方服用的兴奋剂会导致滥用。16%的儿童曾被人找上门要求出售、给予或交换他们的药物。在上课时间，44%的儿童和37%的学校报告称兴奋剂未上锁存放。并非所有学校都有关于处方药的书面政策，10%的学校允许学生自行携带药物。监测处方用药情况、定期重新评估疗效以及对家庭和教职员工进行持续教育应成为这种疾病多模式治疗的一部分。学校政策应在发展方面具有敏感性。
